In rodent trials, a novel immunization revealed potential in shielding against numerous viruses and bacteria, along with a prevalent allergen.(Image credit: sidsnapper via Getty Images)
- Copy link
- X
Share this article 0Join the conversationFollow usAdd us as a favored source on GoogleNewsletterLive ScienceGet the Live Science Newsletter
Receive the planet’s most interesting findings delivered directly into your inbox.
Become a Member in Seconds
Gain instant entry to exclusive member advantages.
Contact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.
You have successfully subscribed
Your subscription to the newsletter was a success
Interested in incorporating additional newsletters?
Delivered DailyDaily Newsletter
Opt in for the newest discoveries, pioneering investigations and captivating breakthroughs that affect you and the global community directly to your inbox.
Signup +
Once a weekLife’s Little Mysteries
Sate your interest with a special mystery each week, deciphered via science and sent straight to your inbox before it’s visible anywhere else.
Signup +
Once a weekHow It Works
Subscribe to our complimentary science & technology bulletin for your regular dose of absorbing articles, concise quizzes, breathtaking images, and more
Signup +
Delivered dailySpace.com Newsletter
Latest space headlines, the newest information on rocket dispatches, celestial viewing occurrences and beyond!
Signup +
Once a monthWatch This Space
Register for our monthly amusement newsletter to stay informed with our full coverage of the cutting-edge sci-fi and space films, tv programs, games and publications.
Signup +
Once a weekNight Sky This Week
Uncover this week’s essential night sky happenings, lunar cycles, and magnificent astrophotos. Subscribe to our stargazing bulletin and delve into the cosmos alongside us!
Signup +Join the club
Obtain complete access to premium content, exclusive features and an expanding catalog of member bonuses.
Explore An account already exists for this email address, please log in.Subscribe to our newsletter
Imagine if one singular vaccine could impart safeguard against an array of disease-causing microbes, ubiquitous allergens, and pulmonary viruses? A recent investigation on mice spotlights an experimental immunization that could conceivably deliver that evasive “broad-spectrum” defense.
Given that it’s exclusively been evaluated in laboratory creatures, the immunization must yet clear multiple rounds of testing in humans before its safety and efficacy can be ascertained.
You may like
-
Cancer vaccine shows promise against HPV-related throat tumors in early study
-
‘DNA origami’ could be key for making an effective HIV vaccine, early study hints
-
A fentanyl vaccine enters human trials in 2026 — here’s how it works
Ordinarily, vaccines educate the immune apparatus to spot a specific antigen, for instance, a protein present on a virus’ facade. Subsequently, the immune system coaches cells to recall and combat that antigen should they encounter it. This culminates in a potent, yet somewhat confined immune bulwark — one that can be circumvented if the designated antigen undergoes mutation over time.
Certain scientists are developing vaccines zeroing in on antigens that exhibit “heightened conservation” across viral forms, implying the antigen varies minimally over periods and bears resemblance from virus to virus. Such inoculations could possibly focus on multiple influenza viruses or a multitude of coronaviruses concurrently, as an illustration. However, the scientists steering the innovative nasal-spray vaccine adopted an alternate strategy: As opposed to exclusively targeting the “adaptive” immune system, which holds in memory precise antigens, it additionally jump-starts the innate immune configuration, a non-specific, initial safeguard.
“What’s noteworthy regarding the innate framework is its capacity to protect against a vast spectrum of disparate microbes,” articulated lead study author Bali Pulendran, a professor in microbiology and immunology stationed at Stanford University School of Medicine, via a declaration.
The concept of a vaccine triggering both innate and adaptive immunity isn’t entirely uncharted. It’s commonly acknowledged that the tuberculosis vaccine, termed Bacillus Calmette-Guérin (BCG), instigates this dual-layered shield. In reality, stemming from that consequence, scientists explored if BCG could furnish extensive defense against COVID-19 during the nascent phases of the pandemic.
Pulendran and associates had formerly scrutinized the BCG vaccine within mice and discerned that the injection prompted immune cells in the lungs to release precise signals. These signals incited innate immune cells inside the lungs to remain energetic for several months, in place of decelerating after mere days.
The innovative nasal-spray vaccine — denoted GLA-3M-052-LS+OVA — functions by replicating those distinctive signals. Furthermore, it integrates an innocuous egg-protein antigen facilitating the assembly of apt immune cells within the lungs. The team discovered that rodents administered three measures of the vaccine spaced over three weeks enjoyed protection against SARS-CoV-2 (the virus instigating COVID-19) along with additional coronaviruses, the bacteria Staphylococcus aureus and Acinetobacter baumannii, and an allergen originating from domestic dust mites for a duration of at least three months subsequently.
Upon introduction to these microbes and the allergen, vaccinated rodents were defended by the heightened innate immune response and swiftly manifested an adaptive immune reaction against the aggressors. Comparatively, unvaccinated rodents fared notably poorer — when subjected to viruses and bacteria, they exhibited amplified lung inflammation, weight reduction and risk pertaining to mortality, and when subjected to allergens, they bore more conspicuous allergic reactions coupled with mucus accrual.
RELATED STORIES
—Vaccine denial sets Americans up for more chronic illness
—’Universal’ cancer vaccine heading to human trials could be useful for ‘all forms of cancer’
—COVID-19 mRNA vaccines can trigger the immune system to recognize and kill cancer, research finds
“This represents a genuinely compelling piece of investigation,” conveyed Daniela Ferreira, a professor specializing in respiratory infection and vaccinology situated at the University of Oxford, and uninvolved with the study, to BBC News. It possesses the potential to “reshape our methodologies for shielding individuals from common coughs, colds and analogous pulmonary ailments” assuming the outcomes are substantiated via human-based investigations, she remarked.
Pulendran underscored also that, hitherto, the vaccine’s assessments have been restricted to laboratory fauna, and supplementary endeavors are requisite to transpose the investigation onto human subjects.
“Should it ultimately demonstrate both safety and effectiveness within human beings, the prospective ramifications could prove transformative: streamlining seasonal vaccination protocols and bolstering preparedness apropos of burgeoning pulmonary threats,” Pulendran communicated to Genetic Engineering and Biotechnology News. Pulendran speculates that a pair of vaccine dosages would likely be defensive among individuals, according to the Stanford declaration.
Disclaimer
This piece serves exclusively for informational dissemination and isn’t conceived to dispense medical counsel.
Article Sources
Zhang, H., Floyd, K., Fang, Z., Hoffmann, F. A., Lee, A., Froggatt, H. M., Bharj, G., Xie, X., Eppler, H. B., Santagata, J. M., Wang, Y., Hu, M., Fox, C. B., Arunachalam, P. S., Baric, R., Suthar, M. S., & Pulendran, B. (2026). Mucosal vaccination in mice provides protection from diverse respiratory threats. Science. https://doi.org/10.1126/science.aea1260
TOPICSvaccines
Nicoletta LaneseSocial Links NavigationChannel Editor, Health
Nicoletta Lanese serves as the health channel editor over at Live Science and formerly functioned as a news editor and staff journalist at the platform. She possesses a postgraduate certificate concerning science communication originating from UC Santa Cruz as well as degrees across neuroscience as well as dance via the University of Florida. Her endeavors have manifested through The Scientist, Science News, the Mercury News, Mongabay coupled with Stanford Medicine Magazine, spanning other distribution points. Anchored within NYC, she additionally sustains strong affiliation concerning dance and partakes inside the choreographic efforts of local performers.
View More
You must confirm your public display name before commenting
Please logout and then login again, you will then be prompted to enter your display name.
LogoutRead more
Cancer vaccine shows promise against HPV-related throat tumors in early study
‘DNA origami’ could be key for making an effective HIV vaccine, early study hints
A fentanyl vaccine enters human trials in 2026 — here’s how it works
‘Nose-in-a-dish’ reveals why the common cold hits some people hard, while others recover easily
An experimental mRNA treatment counters immune cell aging in mice